SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-May-22 9:32 AM View: | Sage Therapeutics, Inc. (SAGE) | 05-May-22 | Private Purchase | 8,000 | $31.45 | $251,563.00 | 100% 0 to 8.0K | |
27-Apr-22 4:05 PM View: | Shattuck Labs, Inc. (STTK) | 26-Apr-22 | Private Purchase | 28,330 | $3.63 | $102,838.00 | 108% 26.28K to 54.61K | |
26-Apr-22 12:26 PM View: | Shattuck Labs, Inc. (STTK) | 22-Apr-22 | Purchase | 234 | $3.67 | $858.78 | < 1% 26.05K to 26.28K | |
26-Apr-22 12:26 PM View: | Shattuck Labs, Inc. (STTK) | 21-Apr-22 | Private Purchase | 26,049 | $3.69 | $96,120.80 | 100% 0 to 26.05K | |
06-Mar-19 4:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 04-Mar-19 | Option Exercise | 9,280 | $36.61 | $339,741.00 | 100% 0 to 9.28K | |
06-Mar-19 4:51 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 04-Mar-19 | Market Option Sale (Planned) | 9,280 | $103.65 | $961,897.00 | (100%) 9.28K to 0 | 59% |
13-Feb-19 8:57 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Option Exercise | 11,228 | $27.88 | $313,012.00 | 100% 0 to 11.23K | |
13-Feb-19 8:57 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Market Option Sale (Planned) | 11,228 | $90.07 | $1,011,300.00 | (100%) 11.23K to 0 | 53% |
13-Feb-19 8:57 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Option Exercise | 2,272 | $25.58 | $58,117.80 | 100% 0 to 2.27K | |
13-Feb-19 8:57 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Market Option Sale (Planned) | 2,272 | $90.03 | $204,552.00 | (100%) 2.27K to 0 | 53% |